A 2025 review shows India’s preterm birth rate at 13%. With over 23% of global preterm births, nearly 150,000 Indian infants ...
Discover the causes of eye floaters, why they occur, when they signify serious eye conditions, and expert advice on what to ...
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...
A 70-year-old man presented to Tufts emergency department with a 2-day history of left eye redness and periorbital swelling ...
Progressive myopia is a growing issue in every country as near vision demands for children continue to increase. In 1980, ...
Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.
Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® (pegcetacoplan) in the first two months since launch in ...
AbbVie today announced positive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib (RINVOQ®;15 mg, once daily  in adult and adolescent patients ...
Visual snow syndrome is that strange, relentless flicker across your entire field of vision like staring at an old TV tuned ...
Vision is one of our most precious senses, yet diabetic retinopathy continues to be a leading cause of blindness among ...